Abc Counseling Llc - Medicare Mental Health Clinic in Rockledge, FL

Abc Counseling Llc is a medicare enrolled mental health clinic (Counselor - Mental Health) in Rockledge, Florida. The current practice location for Abc Counseling Llc is 1802 S Fiske Blvd Ste 201, Rockledge, Florida. For appointments, you can reach them via phone at (321) 446-2113. The mailing address for Abc Counseling Llc is 1802 S Fiske Blvd Ste 201, Rockledge, Florida and phone number is (321) 446-2113.

Abc Counseling Llc is licensed to practice in Florida (license number MH9873). The clinic also participates in the medicare program and its NPI number is 1194235069. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (321) 446-2113.

Contact Information

Abc Counseling Llc
1802 S Fiske Blvd Ste 201
Rockledge
FL 32955-3007
(321) 446-2113
(321) 241-4605

Mental Health Clinic Profile

Full NameAbc Counseling Llc
SpecialityCounselor
Location1802 S Fiske Blvd Ste 201, Rockledge, Florida
Authorized Official Name and PositionChrista Vermillera (OWNER)
Authorized Official Contact3214462113
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Abc Counseling Llc
1802 S Fiske Blvd Ste 201
Rockledge
FL 32955-3007

Ph: (321) 446-2113
Abc Counseling Llc
1802 S Fiske Blvd Ste 201
Rockledge
FL 32955-3007

Ph: (321) 446-2113

NPI Details:

NPI Number1194235069
Provider Enumeration Date10/05/2017
Last Update Date10/31/2023
Certification Date10/31/2023

Medicare PECOS Information:

Medicare PECOS PAC ID8123350733
Medicare Enrollment IDO20191031002444

News Archive

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

Study investigates barriers faced by high schools when implementing state concussion laws

All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

Read more Medical News

› Verified 3 days ago

Medical Identifiers

Medical identifiers for Abc Counseling Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1194235069NPI-NPPES
772265MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
101YM0800XCounselor - Mental Health MH9873 (Florida)Primary
101YM0800XCounselor - Mental Health MH9893 (Florida)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Abc Counseling Llc acts as a billing entity for following providers:
Provider NamePamela D Bratton
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1811900525
PECOS PAC ID: 1951309749
Enrollment ID: I20061109000387

News Archive

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

Study investigates barriers faced by high schools when implementing state concussion laws

All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

Read more Medical News

› Verified 3 days ago

Provider NameMiriam M Vermiller
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1912233537
PECOS PAC ID: 4082063078
Enrollment ID: I20231215003112

News Archive

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

Study investigates barriers faced by high schools when implementing state concussion laws

All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

Read more Medical News

› Verified 3 days ago

Provider NameChrista Vermillera
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1184875312
PECOS PAC ID: 9032441647
Enrollment ID: I20231229002653

News Archive

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

Study investigates barriers faced by high schools when implementing state concussion laws

All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

Read more Medical News

› Verified 3 days ago

News Archive

Emisphere Technologies: Novo Nordisk initiates first Phase I clinical trial of GLP-1

Emisphere Technologies, Inc. today announced that Novo Nordisk has initiated its first Phase I clinical trial with a long-acting oral GLP-1 analogue (NN9924). This milestone releases a $2 million payment to Emisphere, whose proprietary Eligen® Technology is used in the formulation of NN9924.

Jeffrey C. Hall, Michael W. Young and Michael Rosbash to receive 2011 Louisa Gross Horwitz Prize

Columbia University will award the 2011 Louisa Gross Horwitz Prize to Jeffrey C. Hall, Michael Rosbash, and Michael W. Young for their work on the molecular basis of circadian rhythms, the first demonstration of a molecular mechanism for behavior.

Study investigates barriers faced by high schools when implementing state concussion laws

All 50 U.S. states enacted concussion laws between 2009-2014 to mitigate the consequences of concussion. While details of the laws vary from state to state, all state laws address three main factors: concussion education; removal from play after suspected concussion; and return-to-play requirements.

New data from Savient's KRYSTEXXA Phase III trial on refractory chronic gout

Savient Pharmaceuticals, Inc. announced that data providing further clarity and context surrounding the risk for and management of infusion reactions that may occur with KRYSTEXXA (pegloticase) in the treatment of refractory chronic gout (RCG) patients will be presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in Chicago.

New application tool is a user-friendly alternative to previous dietary recall methods

A new website application for athletes called Dietary Analysis Tool for Athletes (D.A.T.A.) has been validated as accurately recording dietary intake based on the 24-hour recall method. "This tool offers sports dietitians and health professionals a new, quick alternative to analyze athletes' dietary intake," said Lindsay Baker, PhD, Principal Scientist, Gatorade Sports Science Institute.

Read more News

› Verified 3 days ago

Counselor in Rockledge, FL

Rockledge Hma, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 110 Longwood Ave, Mail Stop #24, Rockledge, FL 32955
Phone: 321-636-2211    
Total Md Care
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 577 Barnes Blvd Ste 400, Rockledge, FL 32955
Phone: 321-405-2090    
Coastal Mental Health Center Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1281 Florida Ave S Ste 2, Rockledge, FL 32955
Phone: 800-614-4124    Fax: 888-217-4124
Clear As A Bell Psychiatric Providers, Inc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1007 Pathfinder Way Ste 120, Rockledge, FL 32955
Phone: 321-507-4033    
Center For Counseling And Hypnosis, Inc.
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1027 Pathfinder Way, Suite 112, Rockledge, FL 32955
Phone: 321-961-4112    Fax: 321-507-4091
Monarch Educational And Psychological Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 590 Solutions Way Ste 110, Rockledge, FL 32955
Phone: 321-305-4342    
Brevard Achievement Center
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1845 Cogswell St, Rockledge, FL 32955
Phone: 321-632-8610    Fax: 321-639-5087

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.